Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Thomas

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Journal of the National Cancer Institute|May 16, 2020
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-AnalysisRoshni D Kalachand, Britta Stordal, Stephen Madden, et al.
International Journal of Cancer|July 10, 2023
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trialsLaurien J Zeverijn, Eleonora J Looze, Subotheni Thavaneswaran, et al.
JAMA Oncology|August 4, 2017
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysisMandy L Ballinger, Ana Best, Phuong L Mai, et al.
Nature Communications|January 25, 2020
The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderlyMark Pinese, Paul Lacaze, Emma M Rath, et al.
Journal of the National Cancer Institute|September 25, 2025
SMARCAL1 is a new osteosarcoma predisposition geneMaryam Rafati, Lillian M Guenther, Laura E Egolf, et al.
Nature Communications|October 2, 2025
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestryKazzem Gheybi, Pamela X Y Soh, Jue Jiang, et al.
Nature Communications|June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcomaMrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
JAMA Oncology|March 20, 2020
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With OsteosarcomaLisa Mirabello, Bin Zhu, Roelof Koster, et al.
Nature Genetics|June 4, 2013
Genome-wide association study identifies two susceptibility loci for osteosarcomaSharon A Savage, Lisa Mirabello, Zhaoming Wang, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Journal of the National Cancer Institute|May 16, 2020
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-AnalysisRoshni D Kalachand, Britta Stordal, Stephen Madden, et al.
International Journal of Cancer|July 10, 2023
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trialsLaurien J Zeverijn, Eleonora J Looze, Subotheni Thavaneswaran, et al.
JAMA Oncology|August 4, 2017
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysisMandy L Ballinger, Ana Best, Phuong L Mai, et al.
Nature Communications|January 25, 2020
The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderlyMark Pinese, Paul Lacaze, Emma M Rath, et al.
Journal of the National Cancer Institute|September 25, 2025
SMARCAL1 is a new osteosarcoma predisposition geneMaryam Rafati, Lillian M Guenther, Laura E Egolf, et al.
Nature Communications|October 2, 2025
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestryKazzem Gheybi, Pamela X Y Soh, Jue Jiang, et al.
Nature Communications|June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcomaMrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
JAMA Oncology|March 20, 2020
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With OsteosarcomaLisa Mirabello, Bin Zhu, Roelof Koster, et al.
Nature Genetics|June 4, 2013
Genome-wide association study identifies two susceptibility loci for osteosarcomaSharon A Savage, Lisa Mirabello, Zhaoming Wang, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Pageof 22